Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus

被引:41
作者
Sanchez, Elena
Sabio, Jose M.
Callejas, Jose L.
de Ramon, Enrique
Garcia-Portales, Rosa
Garcia-Hernandez, Francisco J.
Jimenez-Alonso, Juan
Francisca Gonzalez-Escribano, Ma
Martin, Javier [1 ]
Koeleman, Bobby P.
机构
[1] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
[2] Hosp Virgen Las Nieves, Med Interna Serv, Granada, Spain
[3] Hosp Clin San Cecilio, Med Interna Serv, Granada, Spain
[4] Hosp Carlos Haya, Med Interna Serv, Malaga, Spain
[5] Hosp Virgen De La Victoria, Serv Reumatol, Malaga, Spain
[6] Hosp Virgen Del Rocio, Med Interna Serv, Seville, Spain
[7] Hosp Virgen Del Rocio, Serv Inmunol, Seville, Spain
[8] Univ Utrecht, Med Ctr, Dept Biomed Genet, Utrecht, Netherlands
关键词
D O I
10.1186/1471-2350-7-48
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Several lines of evidence suggest that chemokines and cytokines play an important role in the inflammatory development and progression of systemic lupus erythematosus. The aim of this study was to evaluate the relevance of functional genetic variations of RANTES, IL-8, IL-1 alpha, and MCP-1 for systemic lupus erythematosus. Methods: The study was conducted on 500 SLE patients and 481 ethnically matched healthy controls. Genotyping of polymorphisms in the RANTES, IL-8, IL-1 alpha, and MCP-1 genes were performed using a real-time polymerase chain reaction (PCR) system with pre-developed TaqMan allelic discrimination assay. Results: No significant differences between SLE patients and healthy controls were observed when comparing genotype, allele or haplotype frequencies of the RANTES, IL-8, IL-1 alpha, and MCP-1 polymorphisms. In addition, no evidence for association with clinical sub-features of SLE was found. Conclusion: These results suggest that the tested functional variation of RANTES, IL-8, IL-1 alpha, and MCP-1 genes do not confer a relevant role in the susceptibility or severity of SLE in the Spanish population.
引用
收藏
页数:8
相关论文
共 34 条
[11]   Replication validity of genetic association studies [J].
Ioannidis, JPA ;
Ntzani, EE ;
Trikalinos, TA ;
Contopoulos-Ioannidis, DG .
NATURE GENETICS, 2001, 29 (03) :306-309
[12]   Chemokines: therapeutic targets for autoimmune and inflammatory renal disease [J].
Kelley, VR ;
Rovin, BH .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 24 (04) :411-421
[13]   The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE [J].
Kim, HL ;
Lee, DS ;
Yang, SH ;
Lim, CS ;
Chung, JH ;
Kim, S ;
Lee, JS ;
Kim, YS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06) :1146-1152
[14]  
Liao CH, 2004, J RHEUMATOL, V31, P2062
[15]   Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus [J].
Lit, LCW ;
Wong, CK ;
Tam, LS ;
Li, EKM ;
Lam, CWK .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (02) :209-215
[16]   Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression [J].
Liu, HL ;
Chao, D ;
Nakayama, EE ;
Taguchi, H ;
Goto, M ;
Xin, XM ;
Takamatsu, J ;
Saito, H ;
Ishikawa, Y ;
Akaza, T ;
Juji, T ;
Takebe, Y ;
Ohishi, T ;
Fukutake, K ;
Maruyama, Y ;
Yashiki, SJ ;
Sonoda, S ;
Nakamura, T ;
Nagai, Y ;
Iwamoto, A ;
Shioda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4581-4585
[17]  
Makki RF, 2000, CLIN EXP RHEUMATOL, V18, P391
[18]   Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study [J].
McDermott, DH ;
Beecroft, MJ ;
Kleeberger, CA ;
Al-Sharif, EM ;
Ollier, WER ;
Zimmerman, PA ;
Boatin, BA ;
Leitman, SF ;
Detels, R ;
Hajeer, AH ;
Murphy, PM .
AIDS, 2000, 14 (17) :2671-2678
[19]  
Mehrian R, 1998, ARTHRITIS RHEUM, V41, P596, DOI 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.3.CO
[20]  
2-U